Literature DB >> 290986

L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.

A E Gal, P G Pentchev, J M Massey, R O Brady.   

Abstract

Procedures for the synthesis and radioactive labeling of L-glucosylceramide are described. This compound is a stereoisomeric analogue of D-glucosylceramide which occurs in nature and accumulates in pathological quantity in the organs and tissues of patients with Gaucher disease. The properties of L-glucosylceramide that have been examined so far have been found to be indistinguishable from those of the naturally occurring glycolipid. However, L-glucosylceramide is completely refractory to enzymatic hydrolysis by purified placental glucocerebrosidase and enzyme(s) present in whole tissue extracts. It is anticipated that L-glucosylceramide will be a uniquely useful substance for exploring pathogenetic processes in animal analogues of Gaucher disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 290986      PMCID: PMC383767          DOI: 10.1073/pnas.76.7.3083

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  A novel chromogenic substrate for assaying glucocerebrosidase activity.

Authors:  A E Gal; P G Pentchev; F J Fash
Journal:  Proc Soc Exp Biol Med       Date:  1976-11

4.  The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.

Authors:  M C Stephens; A Bernatsky; V Burachinsky; G Legler; J N Kanfer
Journal:  J Neurochem       Date:  1978-05       Impact factor: 5.372

5.  Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.

Authors:  P G Pentchev; R O Brady; H E Blair; D E Britton; S H Sorrell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  [Thin-layer chromatographic separation of glycolipids in animal lipid mixtures].

Authors:  N M Neskovic; J L Nussbaum; P Mandel
Journal:  J Chromatogr       Date:  1970-06-03

7.  Gaucher disease in mice induced by conduritol-B-epoxide: morphologic features.

Authors:  M Adachi; B W Volk
Journal:  Arch Pathol Lab Med       Date:  1977-05       Impact factor: 5.534

8.  The distribution and excretion of tritium labeled cerebroside (galactosyl ceramide) radioactivity by the monkey.

Authors:  R M Burton; M A Sodd; W Lewis
Journal:  Lipids       Date:  1969-11       Impact factor: 1.880

9.  Inherited metabolic diseases of the nervous system.

Authors:  R O Brady
Journal:  Science       Date:  1976-08-27       Impact factor: 47.728

10.  Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.

Authors:  F S Furbish; H E Blair; J Shiloach; P G Pentchev; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  1 in total

1.  Detection of trace glucose on the surface of a semipermeable membrane using a fluorescently labeled glucose-binding protein: a promising approach to noninvasive glucose monitoring.

Authors:  Xudong Ge; Govind Rao; Yordan Kostov; Sunsanee Kanjananimmanont; Rose M Viscardi; Hyung Woo; Leah Tolosa
Journal:  J Diabetes Sci Technol       Date:  2013-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.